Purchase Order 75N91018P00523
Award Date 7/17/18
Potential Completion Date 8/16/18
Potential Value $23K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Atlanta Biologicals, Inc. for the procurement of 216 units of ATLANTA BIOLOGICALS INC FETAL BOVINE SERUM PREMIUM. The firm-fixed-price purchase order has a ceiling value of $70,125.30 and an ultimate completion date of April 21, 2017. The contract does not have a set-aside designation. Atlanta Biologicals, Inc. is a for-profit manufacturer of goods and a child...
- Atlanta Biologicals, Inc., a subsidiary of Bio-Techne Corporation, was awarded a Blanket Purchase Agreement (BPA) call contract by the National Cancer Institute valued at $14,623.40 for the provision of biologicals materials, blood and blood products, media, and laboratory supplies. This contract, awarded on July 3, 2018, with an ultimate completion date of August 2, 2018, represents a firm fixed price engagement with no small business set-aside designation. The work is performed at the...
- The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded Atlanta Biologicals, Inc. a $5,380 purchase order contract to deliver Fetal Bovine Serum, Lot #D14043, in reference to Quote #26317. The contract has a period of performance from May 12, 2015 through June 3, 2015 and utilizes a firm fixed price payment structure. Atlanta Biologicals, Inc. will perform as the prime contractor, fulfilling the order from its...
- Atlanta Biologicals, Inc. was awarded a contract by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) for the supply of fetal bovine serum, a critical reagent used in biomedical research and cell culture applications. Executed as a Blanket Purchase Agreement (BPA) call on August 23, 2017, this firm fixed-price contract carried a ceiling value of $17,199.56 and was completed by November 30, 2017. The contract was performed at the awardee's facility in Flowery...
- This is a firm fixed-price contract awarded by the National Cancer Institute, a civilian agency within the U.S. government, to Atlanta Biologicals Incorporated. The contract has a ceiling value of $7,544 and an ultimate completion date of March 27, 2013. The contract type is a BPA (Blanket Purchase Agreement) Call, which suggests it is part of a larger contracting vehicle. The contract is for "OTHER FUNCTIONS ATLANTA BIOLOGICALS INC:1109260 [13-001801]" but no further details are...
- The National Institute of Child Health and Human Development awarded a Blanket Purchase Agreement (BPA) call to Atlanta Biologicals, Inc. for the supply of fetal bovine serum with a ceiling value of $5,368.28. This contract utilized firm fixed price pricing and was executed on August 14, 2017, with an ultimate completion date of August 13, 2018. The work will be performed in Bethesda, Maryland, and no small business set-aside designation was applied to this procurement. Atlanta Biologicals,...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Atlanta Biologicals, Inc., a for-profit manufacturer, for the provision of Fetal Bovine Serum. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type and a ceiling value of $4,895.62. The period of performance runs through August 25, 2016. The contract is not set aside and was awarded on July 25, 2016. Atlanta Biologicals, Inc. is the prime...
- Atlanta Biologicals Incorporated was awarded a firm fixed-price BPA (Blanket Purchase Agreement) call valued at $4,601.74 by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the National Institutes of Health. The contract was awarded on May 8, 2014, with an ultimate completion date of November 30, 2014. The place of performance is located in Bethesda, Maryland. This contract was not issued under any set-aside designation. As a BPA call, this...
- <p>The Office of Administrative Services Procurement Management Branch issued a $65,091.60 delivery order to Biomerieux Inc. on September 1, 2026, for animal species detection kits at the Eastern Lab under Contract 123A9425D0002.</p> <p>Place of performance is Athens, GA 30605. The order carries a firm fixed price and is scheduled for ultimate completion on December 31, 2026. No set-aside was used for this delivery order.</p>
- Atlanta Biologicals Incorporated received a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $15,840 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on September 14, 2013, with a completion date of November 30, 2013, supports closely associated critical functions at the agency's Bethesda, Maryland location. No small business set-aside designation was applied to this...
ATLANTA BIOLOGICALS INC:1109260 [18-051343]
Posted 7/17/18
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 7/17/18 |